Lensar Inc Up 3.53% To $2.08 After Earnings Beat

Lensar Inc (LNSR) said before open Thursday that it lost $0.23 per share in quarter three 2023.

On the revenue line, the company reported $9.8 million, missing estimates by $405 thousand.

In the same quarter a year ago, the company lost $0.39 per share on revenue of $7.7 million.

The stock is up 3.53% to $2.08 after the report.

Despite revenues increasing, earnings decreased, signaling a decline in profit margins.

Trading in the five days leading up to the report earned Lensar Inc a Bearish Sentiment Rank from InvestorsObserver.

Lensar Inc has performed poorly during the past few months, garnering a low Long-Term Technical Rank by InvestorsObserver of 10, putting Lensar Inc in the bottom 25% of stocks. The firm was recently trading at a 52-week low of $1.8 on November 8, 2023 and set a 52-week high on November 16, 2022 at $4.65.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.